News about Gisela Sugranyes
The Clínic-IDIBAPS PROGENDERS Decalogue wins an ISCIII Responsible Research and Innovation Award
The document is aimed at professionals who conduct any type of biomedical research, and aims to improve the quality of the research being carried out1
The institutional KAIROS project of IDIBAPS, funded with 2.5 million euros for impactful biomedical research, has started
The objective is to deepen the molecular and genomic understanding of various diseases and facilitate patient translation. The program has been funde1
Two articles from Clínic-IDIBAPS were selected as best of 2023 by the most relevant scientific journal in child psychiatry
The Journal of American Academy of Child & Adolescent Psychiatry (JAACAP) has selected the eight most relevant articles published in the journal1
IDIBAPS receives 2.5 million euros from the Fortalece-Salud programme to promote biomedical research
The goal of the KAIROS project, driven by 6 Clínic-IDIBAPS research groups, will be to enhance molecular and genetic knowledge about various diseases1
Isabel Blanco, Carlos Fernández de Larrea and Gisela Sugranyes: new senior group leaders (R4) of IDIBAPS
IDIBAPS’s Board of Governors has approved the promotion of Isabel Blanco, Carlos Fernández de Larrea and Gisela Sugranyes from Junior Group Leaders&n1
Fourteen projects with Clínic-IDIBAPS participation receive funding from the 2021 Marató de TV3 fundraiser, devoted to mental health
On 3 November 2022, the TV3 Marató Foundation announced the research projects that will receive funding from the 2021 Marató, dedicated to mental dis1
How to promote the figure of the clinician-scientist in research centers
IDIBAPS is promoting different programs to facilitate professionals combining patient care with biomedical research or enjoying periods of intensive1